tiprankstipranks
Trending News
More News >

Chimeric Therapeutics Announces Extraordinary General Meeting

Story Highlights
Chimeric Therapeutics Announces Extraordinary General Meeting

Don’t Miss TipRanks’ Half-Year Sale

Chimeric Therapeutics Ltd. ( (AU:CHM) ) has shared an announcement.

Chimeric Therapeutics Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for July 23, 2025, to be held both physically in Victoria and virtually online. This meeting provides an opportunity for shareholders to participate and vote on company matters, reflecting the company’s commitment to engaging with its stakeholders and ensuring their involvement in decision-making processes.

More about Chimeric Therapeutics Ltd.

Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative cell therapies for cancer treatment.

Technical Sentiment Signal: Sell

Current Market Cap: A$8.06M

For a thorough assessment of CHM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1